Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Kenneth C. Anderson

1-50 of 669 results

View this query on the Wikidata Query Service
BET bromodomain inhibition as a therapeutic strategy to target c-Myc

scientific article (publication date: 16 September 2011)
A phase 2 study of bortezomib in relapsed, refractory myeloma

scientific article
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

scientific article published in June 2005
Multiple Myeloma

scientific article published in March 2011
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

scientific article
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

scientific article
Initial genome sequencing and analysis of multiple myeloma

scientific article
High-throughput oncogene mutation profiling in human cancer

article
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets

scientific article published on August 2007
Lenalidomide after stem-cell transplantation for multiple myeloma

scientific article
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer

scientific article
NF-kappa B as a therapeutic target in multiple myeloma

scientific article
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

scientific article published on 2 June 2015
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

scientific article
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

scientific article published on 3 August 2015
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

scientific article
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

scientific article published on 03 February 2011
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

scientific article published on January 2014
Multiple myeloma

scientific article published in The Lancet
Molecular sequelae of proteasome inhibition in human multiple myeloma cells

scientific article
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

scientific article published on August 2016
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

scientific article
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

scientific article published in June 2002
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma

scientific article
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

scientific article published on 7 November 2002
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells

scientific article (publication date: 19 August 2003)
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

scientific article published on September 2014
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

scientific article
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

scientific article published on 26 September 2002
Advances in biology of multiple myeloma: clinical applications

scientific article published on 15 April 2004
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

scientific article published on 26 December 2003
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

scientific article published on April 2013
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

scientific article published in March 2004
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

scientific article published on October 27, 2011
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma

scientific article published on 19 January 2012
Proteasome inhibition as a novel therapeutic target in human cancer.

scientific article
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

scientific article published on 13 July 2006
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

scientific article published on 05 May 2009
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

scientific article
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis

scientific article published in April 2007
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

scientific article published on 23 January 2006
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

article
Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

scientific article published in August 2002
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

scientific article published on 17 January 2006
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

scientific article published on 28 September 2007
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

scientific article published on April 2017
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

scientific article published on 09 August 2007
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib

scientific article published on 05 June 2006
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

scientific article
American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

scientific article published on 21 May 2007

Paulina is supported by:

About Paulina

Help